McKesson (MCK) Stock May Be 37% Undervalued On Raised Full Year Guidance

McKesson has ridden a powerful multi‑year run, and the current share price now puts a spotlight on a simple question for investors: Do the company’s underlying cash flows support where the stock trades today, or has sentiment moved faster than the money it generates?

• Over the past 5 years the stock has returned 393.6%, which puts a lot of accumulated optimism on the line when you test the price against what the business can realistically produce in cash over time.
• Recent earnings outperformance and higher full year profit expectations can feed into stronger projected cash generation, which may support a richer valuation if those cash flows prove durable.
• What if you looked at McKesson through its earnings instead? See what McKesson's 26.3x P/E says about the price.

The issue now is whether McKesson’s current market value is justified by the stream of cash flows that its operations are expected to deliver.

If you want to compare McKesson’s cash flow story with other opportunities, a focused screener of 42 high quality undervalued stocks can be a useful next step in your research.

Does McKesson Look Undervalued on Cash Flow?

The Discounted Cash Flow (DCF) model takes McKesson’s future cash flows and discounts them back into today’s dollars. On the latest figures, the business generated last twelve month free cash flow of about $6.7b, and analyst projections in the model point to growing cash generation over the coming decade rather than a shrinking stream.

Those rising cash flow assumptions are paired with a share price of $1,072.00. The DCF output suggests this price is below the value implied by the projected cash being returned to equity holders. Because McKesson recently beat Q2 earnings expectations and raised full year guidance, stronger profit delivery helps explain why the cash flow outlook used in the model supports an intrinsic value that sits substantially above where the stock trades today. Find out what McKesson could be worth using our Discounted Cash Flow (DCF) estimate.

The McKesson Narrative: What Would Justify Today's Price?

Narratives pick up where the McKesson valuation puzzle leaves off by spelling out what would need to happen to future growth, margins and earnings for the stock to be worth materially more or less than today’s price on Simply Wall St’s Community page. Each scenario ties a specific fair value to a clear set of potential catalysts and risks, so you can track over time which version of McKesson’s story is actually unfolding in the numbers.

One of the top community narratives on McKesson: roughly fairly valued

"The current valuation and raised analyst price targets indicate that the share price already reflects confidence in McKesson's oncology and biopharma strategy..."

Discover why this Narrative puts McKesson at roughly fairly valued.

Before you stop at price, one more McKesson check belongs on your list

Cash flows and multiples tell only part of McKesson's story, because the people deciding how capital is used and how they reward themselves can tilt long term outcomes in your favour or away from it. See who runs McKesson and how they are paid.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com